Evidence map›Paper›PMID 39596391›Full record

ArticleInternational journal of molecular sciences2024

Association of Cytotoxic T-Lymphocyte Antigen-4 (

Ana Maria Castro Ferreira, Juliana Carron, Gabriela Vilas Bôas Gomez, Vinicius de Lima Vazquez, Sergio Vicente Serrano, Gustavo Jacob Lourenço, Carmen Silvia Passos Lima

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ana Maria Castro FerreiraLaboratory of Cancer Genetics, School of Medical Sciences, State University of Campinas, Campinas 13083-970, SP, Brazil.
Juliana CarronLaboratory of Cancer Genetics, School of Medical Sciences, State University of Campinas, Campinas 13083-970, SP, Brazil.ORCID 0000-0002-1108-6343
Gabriela Vilas Bôas GomezLaboratory of Cancer Genetics, School of Medical Sciences, State University of Campinas, Campinas 13083-970, SP, Brazil.ORCID 0000-0002-4367-4414
Vinicius de Lima VazquezMelanoma and Sarcoma Surgery Department, Barretos Cancer Hospital, Barretos 14784-400, SP, Brazil.ORCID 0000-0002-0325-5514
Sergio Vicente SerranoDepartment of Medical Oncology, Barretos Cancer Hospital, Barretos 14784-400, SP, Brazil.
Gustavo Jacob LourençoLaboratory of Cancer Genetics, School of Medical Sciences, State University of Campinas, Campinas 13083-970, SP, Brazil.ORCID 0000-0002-5944-0305
Carmen Silvia Passos LimaLaboratory of Cancer Genetics, School of Medical Sciences, State University of Campinas, Campinas 13083-970, SP, Brazil.ORCID 0000-0002-1314-2345

Funding

Coordenação de Aperfeicoamento de Pessoal de Nível Superior 88887.513947/2020-00
6 · The paper itself

Abstract

This study aimed to verify whether germline single nucleotide variants (SNV) in

Indexed as

CTLA-4 AntigenGenetic Predisposition to DiseaseMelanomaPolymorphism, Single NucleotideSkin NeoplasmsAdultAgedApoptosisCase-Control StudiesCell Line, TumorCell MovementCell ProliferationCutaneous Malignant MelanomaFemaleGenotypeHumansCTLA-4 AntigenCTLA4 protein, humanCTLA-4cutaneous melanomaprognosisrisksingle nucleotide variants

Identifiers

PMID39596391
PMCPMC11594856

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.